AML patient clinical characteristics (study 1 and 2).

1There are 25 primary refractory patients and 6 failed patients in Study 2. 2P-values were caluclated as follows: Median survival was estimated from Kaplan-Meier survival curves; the p-value is the log-rank test. Fisher's Exact test or the standard Chi-Square test was used to compare donors with FLT3-ITD, FLT3-WT, or Unknown status with respect to categorical variables. The two-sample ttest was used to compare mean ages of FLT3-ITD and FLT3-WT donors; donors with unknown status were not included in the comparison.